Bortezomib Based Consolidation in Multiple Myeloma Patients Completing Stem Cell Transplant

Clinical trial NCT01706666 · COMPLETED

Trial details

NCT number: NCT01706666
Sponsor: Mayo Clinic
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Stage I Multiple Myeloma Stage II Multiple Myeloma Stage III Multiple Myeloma

Start date: 2012-12-07
Primary completion: 2014-07-10
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.